KeyZell is a Spanish startup that has managed to combine biotechnology with mathematics and develop in a pioneering manner artificial intelligence systems for the diagnosis and treatment of different types of cancer. The AI Diagnosis tool allows to improve the accuracy of cancer diagnosis by imaging through a rapid X-ray test. It is currently working with other tests such as positron emission tomography known as PET and DICOM standards. The Oncology Precision System is the first validated precision medicine system aimed at identifying patterns and making predictions to help oncologists choose the best treatment and therapies based on the patient's unique characteristics. With a presence in Mexico, Australia and Thailand, KeyZell is also focused on the advancement of new anticancer drugs that will provide solutions against tumor cell proliferation and metastasis production.
